Business
Taysha Gene Therapies to Participate in Upcoming September Investor Healthcare Conferences
Citi’s 16th Annual BioPharma Conference on September 8, 2021 Morgan Stanley 19th Annual Global Healthcare Conference on September 9, 2021 at 5:00 pm ET 2021
About this update from Taysha Gene Therapies, Inc.
[{"type":"text","content":"\nCiti’s 16th Annual BioPharma Conference on September 8, 2021\n\nMorgan Stanley 19th Annual Global Healthcare Conference on September 9, 2021 at 5:00 pm ET\n\n2021 Wells Fargo Virtual Healthcare Conference on September 10, 2021 at 1:20 pm ET\n\nHC Wainwright 23rd Annual Global Investment Conference on September 13, 2021 at 7:00 am ET\n\nSVB Leerink CybeRx Series: Neuromuscular, Rare Diseases & Genetic Medicines on September 23, 2021\n\n2021 Cantor Virtual Global Healthcare Conference on September 27, 2021 at 8:00 am ET\n\n DALLAS--(BUSINESS WIRE)--\nTaysha Gene Therapies, Inc. (Nasdaq: TSHA), a patient-centric, pivotal-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system (CNS) in both rare and large patient populations, today announced its participation in the following investor healthcare conferences: Citi’s 16th Annual BioPharma Conference, Morgan Stanley 19th Annual Global Healthcare Conference, 2021 Wells Fargo Virtual Healthcare Conference, HC Wainwright 23rd Annual Global Investment Conference and the 2021 Cantor Virtual Global Healthcare Conference and the SVB Leerink CybeRx Series.\n\nConferences Details:\n\n\n\nEvent:\n\n\n\n\nCiti’s 16th Annual BioPharma Conference\n\n\n\n\n\nDate:\n\n\n\n\nWednesday September 8, 2021\n\n\n\n\n\nFormat:\n\n\n\n\n1x1 meetings\n\n\n\n\n\nParticipants:\n\n\n\n\nRA Session II, President, Founder and CEO\n\n\n\n\n\n\n\nDr. Suyash Prasad, Chief Medical Officer and Head of R&D\n\n\n\n\n\n\n\nKamran Alam, Chief Financial Officer\n\n\n\n\n\n\n\nKimberly Lee, SVP, Corporate Communications and Investor Relations\n\n\n\n\n\n\nEvent:\n\n\n\n\nMorgan Stanley 19th Annual Global Healthcare Conference\n\n\n\n\n\nDate:\n\n\n\n\nThursday September 9, 2021\n\n\n\n\n\nTime:\n\n\n\n\n5:00 pm ET\n\n\n\n\n\nFormat:\n\n\n\n\nFireside chat\n\n\n\n\n\nParticipants:\n\n\n\n\nRA Session II, President, Founder and CEO\n\n\n\n\n\n\n\nDr. Suyash Prasad, Chief Medical Officer and Head of R&D\n\n\n\n\n\n\n\nKamran Alam, Chief Financial Officer\n\n\n\n\n\n\nEvent:\n\n\n\n\n2021 Wells Fargo Virtual Healthcare Conference\n\n\n\n\n\nDate:\n\n\n\n\nFriday September 10, 2021\n\n\n\n\n\nTime:\n\n\n\n\n1:20 pm ET\n\n\n\n\n\nFormat:\n\n\n\n\nFireside chat\n\n\n\n\n\nParticipants:\n\n\n\n\nRA Session II, President, Fou...